From: Prognostic utility of basaloid differentiation in oropharyngeal cancer
Variable | HR | 95% CI | P |
---|---|---|---|
Basaloid differentiation | 0.46 | 0.27-0.76 | 0.003 |
p16 negative | 1.36 | 1.04-1.77 | 0.025 |
Patient variables | |||
Male gender | 0.78 | 0.45-1.33 | 0.36 |
Age | 1.02 | 1.00-1.04 | 0.5 |
Treatment (Surgery + Chemoradiation reference) | |||
Surgery + RT | 1.31 | 0.63-2.73 | 0.461 |
Chemoradiation | 3.51 | 1.76-6.99 | <0.0001 |
Radiation | 8.46 | 4.07-15.80 | <0.0001 |